Geared for Success

Leading Global Supplier of Boranes, Alkali Metal Alkoxides and HMDS Bases

Superior  Quality & Performance

The world's leading expert in Boranes, Alkali Metal Alkoxides and HMDS bases with over 50 years of experience. Callery produces over 50 different high-quality products which enable and enhance our customer’s chemistry consistently through high purity, increased yields and overall performance.  This is evident by our 100% customer audit success rate.

Superior  Quality & Performance

Process Innovation

Callery site operations and R&D are specifically focused on supporting the development, production, packaging and shipping of highly energetic, air sensitive and pyrophoric compounds with a full range of bench scale to commercial capabilities for its line of Boranes and Alkali Metal Alkoxides.

Unparalleled Customer Support

The Callery team provides the best care and training to our customers. Our customer-centric culture and first-in-class product stewardship program provides our customers with an intimate and professional experience. We have a true devotion to customer service and continuous improvement.

Unparalleled Customer Support

Safe & Secure Partner

Callery’s global supply network and logistics expertise ensure safe, secure and timely delivery. Callery boasts a greater than 90% on-time delivery rate. Safety and environmental responsibility are the foundations on which we built our brand shown through our 4-year span without an OSHA recordable incident or injury.

1424 Mars-Evans City Road
Evans City, PA 16033, USA

+1.724.538.1200

Go to article: Home | The Scottish Uprising Go to article: In this issueGo to article: NSFGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: Hapa Company InsightGo to article: BioadviceGo to article: The pharma industry briefingGo to article: Komtur Pharmaceuticals Company InsightGo to article: Komtur PharmaceuticalsGo to article: Where is the UK’s supply of Migraleve?Go to article: AtoZ-CRO GmbH Company InsightGo to article: AtoZ-CRO GmbHGo to article: Drugs from corn? Harvesting Mirexus’ phytoglycogen nano-particleGo to article: Phoenix Group Company InsightGo to article: Phoenix Group Go to article: Castleman disease: does machine learning hold the key to better treatment?Go to article: Capsugel Company InsightGo to article: CalleryGo to article: A health check for Scotland’s pharmaceutical industry Go to article: ImmuMap Company Insight Go to article: ImmuMapGo to article: Moderna’s gamble: what’s behind biotech’s biggest-ever IPO?Go to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: DelSiTech: leveraging silica’s properties to improve drug deliveryGo to article: Alpex Pharma Go to article: AlbypharmaGo to article: ‘Gene genie’: can CRISPR/Cas9 deliver on its promise to transform genome therapy?Go to article: ZenatekGo to article: EventsGo to article: SanofiGo to article: Event: CPhl JapanGo to article: PfanstiehlGo to article: Next issue